Experts Criticize FDA's Plan To Regulate Genomic Tests
This article was originally published in The Gray Sheet
Executive Summary
Legal, ethics and genomic scholars took to the New England Journal of Medicine to criticize FDA's plan to regulate laboratory-developed tests.